Barriers and facilitators of adherence to antidepressants among outpatients with major depressive disorder: A qualitative study

被引:95
作者
Ho, Siew Ching [1 ]
Jacob, Sabrina Anne [2 ]
Tangiisuran, Balamurugan [1 ,3 ]
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, George Town, Malaysia
[2] Monash Univ Malaysia, Sch Pharm, Selangor, Malaysia
[3] Univ Sains Malaysia, Natl Poison Ctr, WHO Collaborating Ctr Drug Informat, George Town, Malaysia
关键词
PRIMARY-CARE; AFRICAN-AMERICANS; PATIENTS BELIEFS; PATIENT TRUST; MEDICATION; ATTITUDES; THERAPY; HEALTH; HARMFULNESS; PREVALENCE;
D O I
10.1371/journal.pone.0179290
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background One of the major challenges in treating major depressive disorder (MDD) is patients' non-adherence to medication. This study aimed to explore the barriers and facilitators of patients' adherence to antidepressants among outpatients with MDD. Methods Semi-structured and individual in-depth interviews were conducted among patients with MDD who were taking antidepressants, in the psychiatric clinic of a government-run hospital in Malaysia. Participants were purposively sampled from different genders and ethnicities. Interviews were conducted using a validated topic guide, and responses were audio-recorded, transcribed verbatim, checked, and analyzed using the grounded theory approach. Results A total of 30 patients were interviewed. Forty different themes and sub-themes were identified which were conceptually divided into two distinct categories related to barriers and facilitators to adherence. The barriers were: patient-specific, medication-specific, healthcare provision and system, social-cultural, and logistics. The facilitators were: having insight, perceived health benefits, regular activities, patient-provider relationship, reminders, and social support networks. Conclusions Patient-specific barriers and medication side effects were the major challenges for adhering to treatment. Perceived health benefits and having insight on the need for treatment were the most frequently cited facilitators. Targeted interventions should be developed to address the key barriers, and promote measures to facilitate adherence in this group of patients.
引用
收藏
页数:19
相关论文
共 84 条
[1]  
Abel Willie M, 2013, Front Public Health, V1, P66, DOI 10.3389/fpubh.2013.00066
[2]   Explaining patients' beliefs about the necessity and harmfulness of antidepressants [J].
Aikens, James E. ;
Nease, Donald E., Jr. ;
Klinkman, Micbael S. .
ANNALS OF FAMILY MEDICINE, 2008, 6 (01) :23-29
[3]   Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication [J].
Aikens, JE ;
Nease, DE ;
Nan, DP ;
Klinkman, MS ;
Schwenk, TL .
ANNALS OF FAMILY MEDICINE, 2005, 3 (01) :23-30
[4]  
Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11
[5]  
Alekhya P., 2015, J Depress Anxiety, V4, P2167
[6]   Patient experiences of taking antidepressants for depression: A secondary qualitative analysis [J].
Anderson, Claire ;
Roy, Tapash .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2013, 9 (06) :884-902
[7]  
[Anonymous], 2011, WHY MEDICATIONS GIVE
[8]  
[Anonymous], DEPRESSION RES TREAT
[9]  
[Anonymous], 2001, The world health report-mental health: New understanding, new hope
[10]  
Ariff Kamil M, 2006, Aust J Rural Health, V14, P2, DOI 10.1111/j.1440-1584.2006.00747.x